RIOCIGUAT for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,837 adverse event reports in the FDA FAERS database where RIOCIGUAT was used for Pulmonary hypertension.
Most Reported Side Effects for RIOCIGUAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 4,500 | 24.6% | 4,498 | 956 |
| Dyspnoea | 2,881 | 15.8% | 443 | 1,875 |
| Headache | 2,462 | 13.5% | 169 | 1,125 |
| Dizziness | 2,208 | 12.1% | 156 | 1,060 |
| Hypotension | 2,192 | 12.0% | 253 | 1,288 |
| Nausea | 2,020 | 11.1% | 189 | 1,061 |
| Hospitalisation | 1,864 | 10.2% | 346 | 1,859 |
| Diarrhoea | 1,790 | 9.8% | 171 | 939 |
| Fatigue | 1,638 | 9.0% | 153 | 851 |
| Vomiting | 1,124 | 6.2% | 118 | 688 |
| Oedema peripheral | 1,018 | 5.6% | 154 | 601 |
| Peripheral swelling | 1,011 | 5.5% | 117 | 567 |
| Fluid retention | 916 | 5.0% | 144 | 669 |
| Cough | 890 | 4.9% | 82 | 497 |
| Dyspepsia | 859 | 4.7% | 43 | 341 |
Other Indications for RIOCIGUAT
Pulmonary arterial hypertension (9,158)
Product used for unknown indication (3,590)
Pulmonary embolism (48)
Cor pulmonale chronic (41)
Heritable pulmonary arterial hypertension (27)
Connective tissue disorder (18)
Heart disease congenital (16)
Systemic scleroderma (13)
Idiopathic pulmonary fibrosis (12)
Scleroderma (12)
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)
LETAIRIS (854)